MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-29-2025
DBV Technologies S.A. DIO Ratio 2011-2026 | DBVT
Annual DIO Ratio DBV Technologies S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | 332 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 332 | 332 | 332 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Adaptive Biotechnologies Corporation
ADPT
|
58 | $ 18.24 | -1.41 % | $ 2.68 B |  USA |
 |
Amgen
AMGN
|
234 | $ 344.45 | 0.75 % | $ 185 B | USA |
 |
Biogen
BIIB
|
394 | $ 178.43 | -0.81 % | $ 26 B | USA |
 |
Aytu BioScience
AYTU
|
209 | $ 2.7 | 3.85 % | $ 17 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | USA |
 |
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | USA |
 |
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M |  Canada |
 |
Akebia Therapeutics
AKBA
|
91.7 | $ 1.39 | -1.42 % | $ 261 M | USA |
 |
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - |  Russia |
 |
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | Canada |
 |
Amneal Pharmaceuticals
AMRX
|
123 | $ 14.11 | 3.14 % | $ 4.36 B | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
892 | $ 6.64 | 0.91 % | $ 1.37 B | USA |
 |
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B |  Cayman-islands |